ZVRA
Zevra Therapeutics Inc.
$8.10
+$0.15(+1.82%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$430.56M
Volume
2.03M
52W Range
$6.19 - $13.16
Target Price
$23.71
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | -- | -- | $12.8M | $13.3M | $28.6M | $10.2M | $27.5M | $23.6M | ||
| Total Revenue | -- | -- | -- | -- | $12.8M | $13.3M | $28.6M | $10.2M | $27.5M | $23.6M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | -- | -- | $2.9M | $-1.3M | $2.1M | $222.0K | $2.2M | $7.4M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | -- | -- | -- | $9.9M | $12.0M | $26.6M | $9.9M | $25.3M | $16.2M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-22.8M | $-37.5M | $-33.4M | $55.9M | $31.9M | $19.1M | $19.0M | $34.8M | $74.9M | $97.0M | ||
| Research & Development | $13.9M | $20.5M | $20.6M | $41.8M | $19.4M | $8.8M | $10.2M | $19.8M | $39.8M | $42.1M | ||
| Research Expense | $13.9M | $20.5M | $20.6M | $41.8M | $19.4M | $8.8M | $10.2M | $19.8M | $39.8M | $42.1M | ||
| Selling, General & Administrative | $8.9M | $14.0M | $12.8M | $12.5M | $10.8M | $7.9M | $8.7M | $15.0M | $35.1M | $54.9M | ||
| General & Administrative Expenses | $8.9M | $14.0M | $12.8M | $12.5M | $10.8M | $7.9M | $8.7M | $15.0M | $35.1M | $54.9M | ||
| Salaries & Wages | $-2.4M | $-6.6M | $-4.6M | $-6.5M | -- | -- | -- | $4.3M | -- | -- | ||
| Depreciation & Amortization | $1.9M | $1.6M | $1.6M | $1.6M | $1.7M | $2.3M | $150.0K | $944.0K | $1.0M | $6.4M | ||
| Depreciation & Amortization | $1.9M | $1.6M | $1.6M | $1.6M | $1.7M | $2.3M | $150.0K | $944.0K | -- | -- | ||
| Amortization | $1.9M | $1.6M | $1.6M | $1.6M | $1.7M | $2.3M | $150.0K | $129.0K | $4.8M | $6.5M | ||
| Other Operating Expenses | $-22.8M | $-37.5M | $-33.4M | -- | $-473.0K | $669.0K | $658.0K | $52.7M | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-24.7M | $-36.1M | $-34.9M | $-55.9M | $-22.0M | $-5.6M | $7.7M | $-24.9M | $-49.6M | $-87.0M | ||
| EBITDA | $-47.3M | $-7.0M | $-39.3M | $-54.7M | $-23.1M | $-5.4M | $-7.9M | $-7.9M | $-43.5M | $-76.4M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $2.7M | $5.5M | $5.8M | $5.5M | $4.9M | $7.1M | $376.0K | $335.0K | $1.5M | $7.4M | ||
| Intinc | $32.0K | $353.0K | $365.0K | $420.0K | $309.0K | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-2.6M | $-5.2M | $-5.4M | $-5.0M | $-4.9M | $-4.8M | $-226.0K | $-425.0K | $-1.5M | $-7.4M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | -- | $-13.0K | $-600.0K | -- | -- | ||
| Other Income/Expense | $27.3M | $-27.7M | $3.1M | $-6.0M | $-2.3M | $95.0K | $15.9M | $-17.9M | $-600.0K | $-18.0B | ||
| Other Special Charges | $-27.3M | $27.7M | $-3.1M | $6.0M | $2.3M | $-95.0K | $-15.9M | $16.1M | $-98.0K | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | $3.0M | -- | $1.6M | -- | $828.0K | -- | $-23.9M | -- | -- | ||
| Special Income Charges | -- | $-3.0M | -- | $-1.6M | -- | $-828.0K | $-2.1M | $23.9M | $45.8M | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | $2.1M | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-52.0M | $-11.0M | $-43.4M | $-56.7M | $-25.0M | $-5.7M | $-8.1M | $-8.8M | $-44.5M | $-82.8M | ||
| Pre-Tax Income | $-54.6M | $-16.5M | $-43.4M | $-56.6M | $-24.5M | $-12.8M | $-8.5M | $-9.1M | $-46.0M | $-90.1M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $26.0K | $-15.0K | $-43.0K | $-126.0K | $-22.0K | $-34.0K | $34.0K | $-33.0K | -- | $15.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $-54.7M | $-16.5M | $-43.4M | $-56.5M | $-24.5M | $-12.8M | $-8.6M | $-9.1M | $-46.0M | $-105.5M | ||
| Net Income (Continuing Operations) | $-54.7M | $-16.5M | $-43.4M | $-56.5M | $-24.5M | $-12.8M | $-8.6M | $-9.1M | $-46.0M | $-105.5M | ||
| Net Income (Discontinued Operations) | $-54.7M | $-16.5M | $-43.4M | $-56.5M | $-24.5M | $-12.8M | $-8.6M | $-9.1M | $-46.0M | $-105.5M | ||
| Net Income (Common Stockholders) | $-54.7M | $-16.5M | $-43.4M | $-56.5M | $-24.5M | $-12.8M | $-62.9M | $-9.1M | $-46.0M | $-105.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-4.7M | -- | -- | -- | ||
| TOTALS | ||||||||||||
| Total Expenses | $-22.8M | $-37.5M | $-33.4M | $55.9M | $34.8M | $17.8M | $21.1M | $35.1M | $77.1M | $104.4M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $7.4M | $14.6M | $14.7M | $17.9M | $29.7M | $4.0M | $29.8M | $34.5M | $35.5M | $46.3M | ||
| Average Shares Outstanding (Diluted) | $7.4M | $14.6M | $14.7M | $17.9M | $29.7M | -- | $29.8M | $34.5M | $35.5M | $46.3M | ||
| Shares Outstanding | $14.5M | $14.6M | $15.1M | $26.5M | $50.7M | $28.4M | $34.4M | $34.5M | $43.4M | $54.1M | ||
| Basic EPS | $-0.64 | $-0.68 | $-0.72 | -- | $-0.83 | $-3.21 | $-2.11 | $-1.2 | $-1.3 | $-2.28 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-0.83 | $-3.21 | $-2.11 | $-1.2 | $-1.3 | $-2.28 | ||
| Diluted EPS | $-7.42 | $-1.13 | $-2.96 | $-3.15 | $-0.83 | $-3.21 | $-2.11 | $-1.2 | $-1.3 | $-2.28 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-2.11 | -- | -- | -- | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | $54.3M | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | $-5.7M | $-5.5M | $-5.4M | $-78.0K | $-218.0K | $-321.0K | -- | -- | ||
| Other Gand A | $8.9M | $14.0M | $12.8M | $12.5M | $10.8M | $7.9M | $8.7M | $15.0M | $35.1M | $54.9M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $6.2M | ||
| Otherunder Preferred Stock Dividend | -- | -- | -- | -- | -- | -- | $54.3M | -- | -- | -- | ||
| Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | $54.3M | -- | -- | -- | ||
| Rent And Landing Fees | $8.9M | $14.0M | $12.8M | $12.5M | -- | -- | -- | -- | $772.0K | -- | ||
| Restruct | -- | $3.0M | -- | $1.6M | -- | $828.0K | -- | $-23.9M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZVRA | $8.10 | +1.8% | 2.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |